EU regulator reviewing menstrual disorder cases after mRNA COVID shots

[February 11, 2022]  (Reuters) - The European Medicines Agency's safety committee said on Friday it was reviewing reports of heavy menstrual bleeding and absence of menstruation with COVID-19 vaccines from Pfizer/BioNTech and Moderna.

The assessment is in view of reports of menstrual disorders with both vaccines, and it is not yet clear whether there is a causal link between the COVID-19 vaccines and the reports, the agency said.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Ramakrishnan M.)

[© 2022 Thomson Reuters. All rights reserved.]  This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.